Skip to main content
Erschienen in: BMC Psychiatry 1/2023

Open Access 01.12.2023 | Research

Neurological soft signs and structural network changes: a longitudinal analysis in first-episode schizophrenia

verfasst von: Li Kong, Christina J. Herold, Silke Bachmann, Johannes Schroeder

Erschienen in: BMC Psychiatry | Ausgabe 1/2023

Abstract

Background

Neurological soft signs (NSS) are often reported in patients with schizophrenia and may vary with psychopathological symptoms during the course of disease. Many cross-sectional neuroimaging studies have shown that NSS are associated with disturbed network connectivity in schizophrenia. However, it remains unclear how these associations change over time during the course of disorder.

Methods

In present study, 20 patients with first-episode schizophrenia and 20 controls underwent baseline structural magnetic resonance imaging (MRI) scan and at one-year follow-up. Structural network characteristics of patients and controls were analyzed using graph theoretical approach based on MRI data. NSS were assessed using the Heidelberg scale.

Results

At baseline, patients demonstrated significant changes of the local network properties mainly involving regions of the cortical-subcortical-cerebellar circuits compared to healthy controls. For further analysis, the whole patient group was dichotomized into a NSS-persisting and NSS-decreasing subgroup. After one-year follow-up, the NSS-persisting subgroup showed decreased betweenness in right inferior opercular frontal cortex, left superior medial frontal cortex, left superior temporal cortex, right putamen and cerebellum vermis and increased betweenness in right lingual cortex. However, the NSS-decreasing subgroup exhibited only localized changes in right middle temporal cortex, right insula and right fusiform with decreased betweenness, and in left lingual cortex with increased betweenness.

Conclusions

These findings provide evidence for brain network reorganization subsequent to clinical disease manifestation in patients with first-episode schizophrenia, and support the hypothesis that persisting NSS refer to progressive brain network abnormalities in patients with schizophrenia. Therefore, NSS could help to establish a better prognosis in first-episode schizophrenia patients.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12888-023-04522-4.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
NSS
Neurological soft signs
MRI
Magnetic resonance imaging
DSM-IV
Diagnostic and statistical manual of mental disorders
SD
Standard deviation
CPZ
Chlorpromazine equivalents
MP-RAGE
Magnetization-prepared rapid gradient echo
TR
Repetition time
TE
Echo time
MNI
Montreal neurological institute
AAL
Automated anatomical labeling
ROIs
Regions of interest
AUC
Areas under curve
FDR
False discovery rate
PANSS
Positive and Negative Syndrome Scale

Background

Neurological soft signs refer to subtle neurological abnormalities of motor and sensory functions and are often reported in patients with schizophrenia. NSS may vary with psychopathological symptoms during the course of the disease [15]. These changes of NSS along the course of schizophrenia were considered to reflect the progression of neurological abnormalities [1, 5]. Many prior studies showed that the severity of NSS is associated with morphometric abnormalities in multiple brain regions, such as decreased grey matter volume or cortical thickness in prefrontal cortex, superior and middle temporal cortex, pre- and post-central cortices, insula, cerebellum, basal ganglia and thalamus [69]. Moreover, NSS are also associated with abnormal functional activation in prefrontal, pre- and post-central cortices, and insula in patients with schizophrenia [912]. Especially, longitudinal studies from our group revealed that the severity of NSS varied with the clinical course [13] and referred to progressive grey matter morphometric changes during the course of disease in patients with first-episode schizophrenia, thus indicating that NSS might help to establish the prognosis in patients with schizophrenia [14].
More recently, network-based approaches provide a powerful access to brain topological organization complementary to conventional morphometric and functional measurements on a more global level [15, 16]. Several groups have examined the neural basis of NSS at network level in patients with schizophrenia [1719]. In a recent study our group reported that the severity of NSS is associated with alterations of structural brain networks corresponding to the cortical-subcortical-cerebellar circuit in patients with schizophrenia [19]. Other studies also found NSS abnormalities to be correlated with altered functional connectivity in multiple brain networks in patients with schizophrenia [17, 18]. However, longitudinal studies investigating the associations between NSS and changes of network characteristics over time in patients with schizophrenia are rather scarce, although this approach reduces the potentially confounding effects of intra-individual variability.
In the present study, graph theory-based approaches were used to examine structural network characteristics and their associations with the severity of NSS. Graph theory is a powerful method for quantifying the brain as a complex network [20]. It provides unique insight into the structural architecture of the brain to assess the integration and segregation of the brain network. Therefore, based on our earlier findings of NSS related longitudinal grey matter morphometric changes and cross-sectional structural networks alterations, we extended our previous work by exploring the longitudinal relationship between the severity of NSS and changes of brain network characteristics during a one-year follow-up in patients with first-episode schizophrenia. We hypothesized that persisting NSS refer to progressive alterations of brain network characteristics in patients with first-episode schizophrenia.

Methods and materials

Participants

For the present study, we used data from a previous publication, in which we examined the longitudinal relationships between NSS and grey matter volume changes in first-episode schizophrenia [14]. Detailed information on the subjects’ characteristics has been given before [14]. They are exhibited in Table 1. Twenty participants (7 males) with first-episode schizophrenia were recruited from the Department of Psychiatry, University of Heidelberg, Germany. Patients’ diagnoses were established using the German version of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [21]. Psychopathological symptoms were rated on the Positive and Negative Syndrome Scale (PANSS) [22]. None of the patients had a history of severe substance abuse or neurological disorder. All patients were again examined after a mean duration of 13.8 months (Standard Deviation, SD = 1.6). At baseline patients received atypical antipsychotics with a mean dose of 549.3 mg/day (SD = 271.3) of chlorpromazine equivalents (CPZ; [23]). Sixteen patients (80%) adhered to psychiatric treatment regularly with a mean dose of 443.8 mg/day CPZ (SD = 137.7) during the follow-up period. Twenty healthy individuals were recruited through advertisements and included in the study. The group comprised 10 males and 10 females with a mean age of 24.1 years (SD = 3.5) and 11.9 years (SD = 1.5) of education. None of the participants had any major psychotic disorders, history of neurological or medical illness, head injury or substance abuse. The study was approved by the ethics committee of the Medical Faculty, University of Heidelberg, Germany. All participants provided written informed consent after full explanation of the proceedings.
Table 1
Clinical and demographic variables
Variables Mean (SD)
Healthy Controls
Patients (Baseline)
Patients (Follow-up)
P-value
Age (year)
24.1 (3.5)
25.6 (7.2)
/
0.52
Sex(male/female)
10/10
7/13
/
0.34
Chlorpromazine equivalents (mg/day)
/
549.3 (271.3)
443.8(137.7)
0.17
NSS
3.6 (1.6)
15.3 (6.8)
11.30 (8.31)
< 0.001a
NSS subgroups
 
Decreasing NSS (n = 10)
Persisting NSS (n = 10)
 
 
Baseline
Follow-up
Baseline
Follow-up
 
NSS
15.9 (3.9)
7.2 (3.5)
14.6 (9.2)
14 (9.5)
< 0.001b
PANSS
51.2 (9.8)
44.2 (9.9)
50.1(13.6)
52.8(22.8)
0.28b
Age at baseline
26.1 (6.5)
25.0 (8.2)
0.66
Sex(male/female)
3/7
4/6
0.64
NSS Neurological soft signs, PANSS Positive and negative syndrome scale, SD Standard deviation
a: p-value for the difference between healthy controls and patients at baseline
b: repeated ANOVAs in two subgroups
NSS were assessed at baseline and follow-up with the Heidelberg Scale [4], which is well established and widely used in neuropsychiatric diseases [2428]. It includes 5 subscales comprising 16 items. Ratings were given on a 0–3-point scale (no/slight/moderate/marked abnormality). In order to further investigate the changes of NSS over time, the whole patients group (20 patients) were divided into 2 subgroups based on the mean change of NSS total scores. There were 10 patients with a notable decrease in total NSS scores (NSS-decreasing subgroup: 3 males, 7 females; mean age: 26.1 years (SD = 6.5); change of NSS: 5 ~ 18) and 10 patients with persisting or increasing NSS level (NSS-persisting subgroup: 4 males, 6 females; mean age: 25.0 years (SD = 8.2); change of NSS: − 10 ~ 4). The changes of PANSS scores in both subgroups were also summarized in Table 1.

MRI acquisition

Structural MRI data of all participants were obtained at the German Cancer Research Centre with a 1.5 T Magnetom Vision MR scanner (Siemens Medical Solutions, Erlangen, Germany) with the following parameters: magnetization-prepared rapid gradient echo (MP-RAGE), 126 coronal slices, image matrix = 256 × 256, voxel size = 0.98 × 0.98 × 1.8 mm3, repetition time (TR) = 10 ms, echo time (TE) = 4 ms, flip angle = 12°.

Image preprocessing and analysis

In order to compare the present network results with our earlier grey matter volume findings from the same sample [14], we kept using the same preprocessing tools with VBM8 (http://​dbm.​neuro.​uni-jena.​de/​vbm) in SPM8 (http://​www.​fil.​ion.​ucl.​ac.​uk/​spm) on Matlab 2013 platform (http://​www.​mathworks.​com/​products/​matlab). Detailed steps of VBM8 have been described in previous studies (Ashburner and Friston, 2000; Good et al., 2001). Briefly, it included (1) normalization of all images to a Montreal Neurological Institute (MNI) template; (2) normalized brain images were segmented into grey matter, white matter, and cerebrospinal fluid compartments; and (3) normalized grey matter images were modulated.
The WFU PickAtlas Toolbox was used to extract 116 regions of interest (ROIs) using the Automated Anatomical Labeling (AAL) atlas [29]. These cerebral ROIs were re-sliced based on the normalized grey matter images. The REX toolbox (https://​web.​mit.​edu/​swg/​software.​htm) was then used to extract ROI volumes from the modulated and normalized grey matter images.

Network construction and measurements

In the present study, the 116 extracted AAL ROIs were defined as nodes, and the Pearson correlation coefficients between ROIs represented the edges. Structural correlation matrices were then constructed by calculating the correlation coefficients between regions for each group. Age and gender were entered as covariates to control for potential confounding effects. Binary adjacency matrices were then derived based on the association matrices by thresholding a range of densities. The lower bound of the range was determined in which all nodes were fully connected. The upper bound of the range was 0.5 according to previous results, as grey matter structural networks became less biological above this bound [30, 31].
To investigate the global topological properties of a network, clustering coefficient (C) and characteristic path length (L) were calculated [3133]. The clustering coefficient of a node is a measurement of the number of connections between its directly neighboring regions, and the clustering coefficient of a network is the average of the clustering coefficient, which reflects the segregation of the network [31]. The characteristic path length is the average shortest passing through the node, which reflects the integration of the network. The small-world index of the network was defined as (C/Crand)/ (L/Lrand), where Crand and Lrand are the mean clustering coefficient and the characteristic path length of the random network [34]. A network with small-world index means that it has a significantly higher clustering coefficient than in random networks, and comparable characteristics path length to that in random networks [33].
Regional network characteristics of the constructed structural networks were assessed based on nodal betweenness centrality for each of the anatomical ROIs at minimum density with full connectivity for the network. Nodal betweenness represents the fraction of all shortest paths in the network that pass through, which can defect important anatomical or functional connections [35].
The hubs represent the importance of the nodes and are crucial regulators for efficient information communication in brain networks [31]. A node was set as a hub if its betweenness was at least two SDs above the mean betweenness [33, 36].

Statistical analysis

The clinical and demographic data were analyzed using Student’s t tests for continuous variables and Chi-squared tests for categorical variables in SPSS 22. Repeated measures ANOVA were performed to examine time effects and group effects for NSS and PANSS scores.
To investigate the differences of the global and regional network measures between groups, parametric t-tests and nonparametric tests with 1000 repetitions were performed using GAT software [33, 36]. After calculating group differences at each density, areas under curve (AUC) were then performed for each network measures so that the between-group differences were less sensitive to the thresholding values. In an exploratory fashion, we assessed changes in network characteristics over one-year follow-up between the two subgroups. Two-tailed p values were obtained based on its percentile position [33, 37], and false discovery rate (FDR) corrected p values were also reported to correct for multiple comparisons with p < 0.05.

Results

Demographic data

The clinical and demographic characteristics of the sample are summarized in Table 1. There were no significant differences in age and sex between healthy controls and patients with schizophrenia. NSS scores in patients are significantly higher than in healthy controls (p < 0.001). Repeated measures ANOVA analysis showed a significant reduction of NSS in the decreasing-NSS subgroup compared to that in the persisting-NSS subgroup (p < 0.001). In addition, compared with the persisting-NSS subgroup, the decreasing-NSS subgroup tended to have a more favorable one-year outcome as indicated by scores on the PANSS; however, the differences between the two subgroups were not statistically significant.

Cross-sectional network measurements in the whole group

There were no significant differences with respect to global network measures between patients with schizophrenia and healthy controls at baseline. AUC analysis showed that patients with schizophrenia demonstrated significant changes in local network properties and network hubs compared to controls mainly involving regions of cortical-subcortical-cerebellar circuits. Detailed information is described in the supplementary file (Figure S1 for local network properties and Figure S2 for network hubs).

Longitudinal network measurements in two subgroups

Both NSS-persisting and NSS-decreasing subgroups followed small-world characteristics at baseline and follow-up. After the one-year follow-up, both subgroups did not show significant global network differences including the small-world index, clustering coefficient and path length.
AUC analysis showed that the NSS-persisting subgroup developed longitudinally significant reductions of local betweenness mainly involving right opercular inferior frontal cortex, left medial superior frontal cortex, left superior temporal cortex, right putamen and cerebellum vermis, while betweenness became larger in right lingual cortex (Fig. 1a). For the NSS-decreasing subgroup, patients demonstrated a significant smaller betweenness at follow-up in right middle temporal cortex, right insula and right fusiform, while betweenness became larger in left lingual cortex. However, none of the involved regions survived the correction for multiple comparisons (p < 0.05, FDR corrected) (Fig. 1b).
The network hubs of the NSS-persisting subgroup at baseline were identified in left orbital inferior frontal cortex, left middle temporal cortex, right putamen, and cerebellum vermis; after one-year follow-up, the network hubs were observed in left and right orbital inferior frontal cortices, left triangular inferior frontal cortex, left postcentral cortex and left and right middle temporal cortices (Fig. 2a). The network hubs of the NSS-decreasing subgroup at baseline were identified in left opercular and triangular inferior frontal cortices, right medial superior frontal cortex, left inferior temporal cortex, right fusiform and right cerebellum; after one-year of follow-up, the network hubs located in left middle and inferior temporal cortices, left angular and left cerebellum (Fig. 2b).

Discussion

In the present study, we conducted a longitudinal design to link NSS trajectories with dynamic changes in structural network properties during the course of first-episode schizophrenia. The main results were as follows: (1) the NSS-persisting subgroup showed more widespread local betweenness changes at follow-up involving frontal and temporal cortices, insula, putamen and cerebellum than the NSS-decreasing subgroup; (2) different alterations of network-hub distributions were observed between NSS-persisting and NSS-decreasing subgroups from baseline to follow-up.
Before splitting the whole group into NSS-persisting and NSS-decreasing subgroups, we first performed a cross-sectional analysis to compare the network properties between patients with schizophrenia and healthy controls. Our results showed that there were no significant differences in global network measures between patients with schizophrenia and healthy controls. However, regional network analyses showed significantly changed betweenness centrality, especially in areas of cortical-subcortical-cerebellar circuits. These results were generally consistent with previous cross-sectional studies investigating structural network characteristics between patients with schizophrenia and healthy controls, and further confirmed a disturbed cortical-subcortical-cerebellar circuitry in schizophrenia [3840].
Further longitudinal analyses demonstrated that both NSS-persisting and NSS-decreasing subgroups did not demonstrate significant changes in global network topologies over one-year follow-up. This stability suggests that crucial characteristics of the network are highly preserved over one-year follow-up in patients with first-episode schizophrenia. With respect to the local betweenness centrality, the NSS-persisting subgroup showed a more widespread variety in betweenness centrality than the NSS-decreasing subgroup at follow-up in contrast to baseline, mainly involving right opercular inferior frontal cortex, left medial superior frontal cortex, left superior temporal cortex, right putamen and cerebellum vermis. The present results not only provide additional evidence that brain network topologies change over time, but also suggest that NSS severity was associated with progressions of network characteristics, especially involving the cortical-subcortical-cerebellar circuit in patients with fist-episode schizophrenia. This NSS-related brain network variety over time is generally in line with results from our previous cross-sectional study that showed NSS severity to be associated with alterations in topological attributes of brain networks corresponding to the cortical-subcortical-cerebellar circuit in patients with schizophrenia [19]. Alterations in local network properties in these regions indicated an abnormal ability for modulating information flow and participating in functional interactions with their adjacent regions [33]. Therefore, NSS may present a clinical phenotype of the dynamic changes in brain networks that putatively underlies the neurobiology of schizophrenia.
In addition, in our previous longitudinal study in which we investigated NSS-related grey matter morphometric changes over one-year follow-up, we reported more pronounced grey matter volumetric reduction over time in the NSS-persisting group than in the NSS-decreasing group mainly located in cortical structures and cerebellum [14]. A significant difference to the present results is that we now identified NSS-related network variety over time, which also includes subcortical putamen in addition to cortical and cerebellar regions. Prior cross-sectional studies investigating NSS-related grey matter morphometric characteristics often described that NSS are associated with abnormalities in the putamen [6, 41]. The putamen receives input from sensorimotor cortex and related to other parts of the basal ganglia and cortical structures, which plays an important role in modulating sequential motor functions [42]. Some studies also reported that smaller putamen is associated with poorer outcome in schizophrenia [43]. However, our earlier longitudinal study based on morphometric analysis could not identify significant changes of putamen volume during disease duration of one year [14]. Instead, the present network analysis revealed quantifiable varieties in putamen during the one-year follow-up period, which may suggest that network analysis is much more sensitive to minor changes in rather small cerebral structures than morphometric methods.
Network analysis further identified alterations of hub distribution in both subgroups from baseline to one-year follow-up. The network hubs of the NSS-persisting subgroup changed significantly over time mainly involving inferior frontal cortex, middle temporal cortex, postcentral cortex, putamen and cerebellum. The network hubs of the NSS-decreasing subgroup changed significantly over time mainly involving inferior frontal cortex, inferior and middle temporal cortices, angular and cerebellum. Similar to the above-described results of local betweenness, the alterations of hubs in the subcortical region putamen were only identified in the NSS-persisting subgroup, especially at the baseline assessment. These results suggest that the abnormality of the putamen at baseline may relate to the persisting of NSS one year later and further heralds chronicity of schizophrenia. Hubs are key parts of efficient information communication and regulation in a network [33]. The present NSS-related alterations of hub distributions indicate a less efficient information transmission in the cortical-subcortical-cerebellar circuitry and also suggest a reconfiguration of brain networks. These results further confirm that NSS are related to disturbed cortical-subcortical-cerebellar circuitry in schizophrenia longitudinally at network level.
In addition, our results also indicate that the decreasing-NSS subgroup tend to have a more favorable outcome with respect to PANSS sum score compared to the persisting-NSS subgroup, although the difference did not reach significance. However, whether there is a parallel development between psychopathology (PANSS) and NSS in schizophrenia remains unclear. Some studies demonstrated a parallelism of PANSS with the severity of NSS in schizophrenia [44], but others not [45]. Nevertheless, our present findings indicate that grouping patients based on NSS could create more homogeneous subgroups, therefore allowing a more sensitive detection of network changes linked to the course of schizophrenia.
We have also shown that distinct patterns of networks correlated significantly with NSS severity over time in patients with schizophrenia. The utilization of longitudinal network-NSS profiling analysis allowed us to tighter differentiate between clinical phenotypes (i.e. NSS-groups) and their underlying neurobiology, thus providing important information to complement existing methods of patient assessment.
The main strength of the present study is its longitudinal design to investigate NSS-related structural changes at a network level in schizophrenia. A potential limitation of the study is our small sample size, which may limit the generalization of our results. Additionally, the lack of a healthy control group at follow-up limits our ability to comment on whether the patterns of NSS related network changes are different from those in healthy participants. However, a recent study investigating network changes in healthy controls over one year did not identify significant variations of network properties [46]. Effects of medication are also potential confounding variables, although clinical studies demonstrated that NSS are not the sequelae of antipsychotic treatment [47].

Conclusions

To the best of our knowledge, this is the first longitudinal study that focused on to NSS trajectories with dynamic changes in structural network properties in patients with schizophrenia. Our results suggest that NSS severity is associated with variability of structural network characteristics, especially involving cortical-subcortical-cerebellar circuits, which may underlie the heterogeneity of NSS trajectories in first-episode schizophrenia. The present results may provide a new perspective for elucidating the neural basis of NSS in schizophrenia.

Acknowledgements

Many thanks to all study participants.

Declarations

The study was approved by the ethics committee of the Medical Faculty, University of Heidelberg, Germany. All participants provided written informed consent. All procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration.
Not applicable.

Competing interests

All authors report no financial interest or conflict of interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Bachmann S, Degen C, Geider FJ, Schroder J. Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis. Front Psychiatry. 2014;5:185.CrossRef Bachmann S, Degen C, Geider FJ, Schroder J. Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis. Front Psychiatry. 2014;5:185.CrossRef
2.
Zurück zum Zitat Chan RCK, Xu T, Heinrichs RW, Yu Y, Wang Y. Neurological Soft Signs in Schizophrenia: A Meta-analysis. Schizophr Bull. 2010;36(6):1089–104.CrossRef Chan RCK, Xu T, Heinrichs RW, Yu Y, Wang Y. Neurological Soft Signs in Schizophrenia: A Meta-analysis. Schizophr Bull. 2010;36(6):1089–104.CrossRef
3.
Zurück zum Zitat Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. The American journal of psychiatry 1988. Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. The American journal of psychiatry 1988.
4.
Zurück zum Zitat Schröder J, Niethammer R, Geider F-J, Reitz C, Binkert M, Jauss M, Sauer H. Neurological soft signs in schizophrenia. Schizophr Res. 1992;6(1):25–30.CrossRef Schröder J, Niethammer R, Geider F-J, Reitz C, Binkert M, Jauss M, Sauer H. Neurological soft signs in schizophrenia. Schizophr Res. 1992;6(1):25–30.CrossRef
5.
Zurück zum Zitat Lui SSY, Yip SSL, Wang Y, Hung KSY, Ho KKY, Tsang KCM, Yeung HKH, Cheung EFC, Chan RCK. Different trajectories of neurological soft signs progression between treatment-responsive and treatment-resistant schizophrenia patients. J Psychiatr Res. 2021;138:607–14.CrossRef Lui SSY, Yip SSL, Wang Y, Hung KSY, Ho KKY, Tsang KCM, Yeung HKH, Cheung EFC, Chan RCK. Different trajectories of neurological soft signs progression between treatment-responsive and treatment-resistant schizophrenia patients. J Psychiatr Res. 2021;138:607–14.CrossRef
6.
Zurück zum Zitat Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallett RM. The structural brain correlates of neurological soft signs in ÆSOP first-episode psychoses study. Brain. 2004;127(1):143–53.CrossRef Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallett RM. The structural brain correlates of neurological soft signs in ÆSOP first-episode psychoses study. Brain. 2004;127(1):143–53.CrossRef
7.
Zurück zum Zitat Hirjak D, Wolf RC, Stieltjes B, Hauser T, Seidl U, Thiemann U, Schröder J, Thomann PA. Neurological soft signs and brainstem morphology in first-episode schizophrenia. Neuropsychobiology. 2013;68(2):91–9.CrossRef Hirjak D, Wolf RC, Stieltjes B, Hauser T, Seidl U, Thiemann U, Schröder J, Thomann PA. Neurological soft signs and brainstem morphology in first-episode schizophrenia. Neuropsychobiology. 2013;68(2):91–9.CrossRef
8.
Zurück zum Zitat Kong L, Herold CJ, Lässer MM, Schmid LA, Hirjak D, Thomann PA, Essig M, Schröder J. Association of cortical thickness and neurological soft signs in patients with chronic schizophrenia and healthy controls. Neuropsychobiology. 2015;71(4):225–33.CrossRef Kong L, Herold CJ, Lässer MM, Schmid LA, Hirjak D, Thomann PA, Essig M, Schröder J. Association of cortical thickness and neurological soft signs in patients with chronic schizophrenia and healthy controls. Neuropsychobiology. 2015;71(4):225–33.CrossRef
9.
Zurück zum Zitat Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC. Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull. 2014;40(3):626–41.CrossRef Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC. Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull. 2014;40(3):626–41.CrossRef
10.
Zurück zum Zitat Zhao W, Guo S, Linli Z, Yang AC, Lin C-P, Tsai S-J. Functional, anatomical, and morphological networks highlight the role of basal ganglia–thalamus–cortex circuits in schizophrenia. Schizophr Bull. 2020;46(2):422–31. Zhao W, Guo S, Linli Z, Yang AC, Lin C-P, Tsai S-J. Functional, anatomical, and morphological networks highlight the role of basal ganglia–thalamus–cortex circuits in schizophrenia. Schizophr Bull. 2020;46(2):422–31.
11.
Zurück zum Zitat Schröder J, Essig M, Baudendistel K, Jahn T, Gerdsen I, Stockert A, Schad LR, Knopp MV. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage. 1999;9(1):81–7.CrossRef Schröder J, Essig M, Baudendistel K, Jahn T, Gerdsen I, Stockert A, Schad LR, Knopp MV. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage. 1999;9(1):81–7.CrossRef
12.
Zurück zum Zitat Rubia K, Russell T, Bullmore ET, Soni W, Brammer MJ, Simmons A, Taylor E, Andrew C, Giampietro V, Sharma T. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res. 2001;52(1–2):47–55.CrossRef Rubia K, Russell T, Bullmore ET, Soni W, Brammer MJ, Simmons A, Taylor E, Andrew C, Giampietro V, Sharma T. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res. 2001;52(1–2):47–55.CrossRef
13.
Zurück zum Zitat Bachmann S, Bottmer C, Schroeder J. Neurological Soft Signs in First-Episode Schizophrenia A Follow-Up Study. Am J Psychiatry. 2005;162:2337–43.CrossRef Bachmann S, Bottmer C, Schroeder J. Neurological Soft Signs in First-Episode Schizophrenia A Follow-Up Study. Am J Psychiatry. 2005;162:2337–43.CrossRef
14.
Zurück zum Zitat Kong L, Bachmann S, Thomann PA, Essig M, Schröder J. Neurological soft signs and gray matter changes: A longitudinal analysis in first-episode schizophrenia. Schizophr Res. 2012;134:27–32.CrossRef Kong L, Bachmann S, Thomann PA, Essig M, Schröder J. Neurological soft signs and gray matter changes: A longitudinal analysis in first-episode schizophrenia. Schizophr Res. 2012;134:27–32.CrossRef
15.
Zurück zum Zitat Sporns O, Chialvo DR, Kaiser M, Hilgetag CC. Organization, development and function of complex brain networks. Trends Cogn Sci. 2004;8(9):418–25.CrossRef Sporns O, Chialvo DR, Kaiser M, Hilgetag CC. Organization, development and function of complex brain networks. Trends Cogn Sci. 2004;8(9):418–25.CrossRef
16.
Zurück zum Zitat Hadley JA, Kraguljac NV, White DM, Ver Hoef L, Tabora J, Lahti AC. Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory. NPJ Schizophr. 2016;2:16014.CrossRef Hadley JA, Kraguljac NV, White DM, Ver Hoef L, Tabora J, Lahti AC. Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory. NPJ Schizophr. 2016;2:16014.CrossRef
17.
Zurück zum Zitat Dong D, Wang Y, Chang X, Luo C, Yao D. Dysfunction of Large-Scale Brain Networks in Schizophrenia: A Meta-analysis of Resting-State Functional Connectivity. Schizophr Bull. 2018;44(1):168–81.CrossRef Dong D, Wang Y, Chang X, Luo C, Yao D. Dysfunction of Large-Scale Brain Networks in Schizophrenia: A Meta-analysis of Resting-State Functional Connectivity. Schizophr Bull. 2018;44(1):168–81.CrossRef
18.
Zurück zum Zitat Galindo L, Berge D, Murray GK, Mane A, Bulbena A, Perez V, Vilarroya O. Default Mode Network Aberrant Connectivity Associated with Neurological Soft Signs in Schizophrenia Patients and Unaffected Relatives. Front Psych. 2017;8:298.CrossRef Galindo L, Berge D, Murray GK, Mane A, Bulbena A, Perez V, Vilarroya O. Default Mode Network Aberrant Connectivity Associated with Neurological Soft Signs in Schizophrenia Patients and Unaffected Relatives. Front Psych. 2017;8:298.CrossRef
19.
Zurück zum Zitat Kong L, Herold CJ, Cheung EF, Chan RC, Schröder J: Neurological Soft Signs and Brain Network Abnormalities in Schizophrenia. Schizophrenia bulletin 2019. Kong L, Herold CJ, Cheung EF, Chan RC, Schröder J: Neurological Soft Signs and Brain Network Abnormalities in Schizophrenia. Schizophrenia bulletin 2019.
20.
Zurück zum Zitat Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10(3):186–98.CrossRef Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10(3):186–98.CrossRef
21.
Zurück zum Zitat Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. SKID-I: Strukturiertes klinisches Interview für DSM-IV. Göttingen: Hogrefe; 1997. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. SKID-I: Strukturiertes klinisches Interview für DSM-IV. Göttingen: Hogrefe; 1997.
22.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRef Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRef
23.
Zurück zum Zitat Lehamn A, Steinwachs D. At issue: translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendation. Schizophr Bull. 1998;24:1Á10. Lehamn A, Steinwachs D. At issue: translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendation. Schizophr Bull. 1998;24:1Á10.
24.
Zurück zum Zitat Escudero DQ, Herold CJ, Kong L, Schröder J. Neurological soft signs (NSS) and gray matter volume (GMV) in first-episode psychosis: an analysis of NSS motor subscores. Psychiatry Res: Neuroimaging. 2020;300:111067.CrossRef Escudero DQ, Herold CJ, Kong L, Schröder J. Neurological soft signs (NSS) and gray matter volume (GMV) in first-episode psychosis: an analysis of NSS motor subscores. Psychiatry Res: Neuroimaging. 2020;300:111067.CrossRef
25.
Zurück zum Zitat Forno G, Henríquez F, Ceballos ME, Gonzalez M, Schröder J, Toro P. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder. Neuropsychologia. 2020;146:107545.CrossRef Forno G, Henríquez F, Ceballos ME, Gonzalez M, Schröder J, Toro P. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder. Neuropsychologia. 2020;146:107545.CrossRef
26.
Zurück zum Zitat Herold CJ, Duval CZ, Lässer MM, Schröder J. Neurological soft signs (NSS) and cognitive impairment in chronic schizophrenia. Schizophrenia Res: Cognition. 2019;16:17–24. Herold CJ, Duval CZ, Lässer MM, Schröder J. Neurological soft signs (NSS) and cognitive impairment in chronic schizophrenia. Schizophrenia Res: Cognition. 2019;16:17–24.
27.
Zurück zum Zitat Herold CJ, Kong L, Ceballos ME, Schröder J, Toro P. Neurological soft signs and brain morphology in people living with HIV. J NeuroVirol. 2022;28:1–12.CrossRef Herold CJ, Kong L, Ceballos ME, Schröder J, Toro P. Neurological soft signs and brain morphology in people living with HIV. J NeuroVirol. 2022;28:1–12.CrossRef
28.
Zurück zum Zitat Seidl U, Thomann PA, Schroeder J. Neurological soft signs in nursing home residents with Alzheimer’s disease. J Alzheimers Dis. 2009;18(3):525–32.CrossRef Seidl U, Thomann PA, Schroeder J. Neurological soft signs in nursing home residents with Alzheimer’s disease. J Alzheimers Dis. 2009;18(3):525–32.CrossRef
29.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273–89.CrossRef Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273–89.CrossRef
30.
Zurück zum Zitat Kaiser M, Hilgetag CC. Nonoptimal component placement, but short processing paths, due to long-distance projections in neural systems. PLoS Comput Biol. 2006;2(7):e95.CrossRef Kaiser M, Hilgetag CC. Nonoptimal component placement, but short processing paths, due to long-distance projections in neural systems. PLoS Comput Biol. 2006;2(7):e95.CrossRef
31.
Zurück zum Zitat Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage. 2010;52(3):1059–69.CrossRef Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage. 2010;52(3):1059–69.CrossRef
32.
Zurück zum Zitat Sporns O, Zwi JD. The small world of the cerebral cortex. Neuroinformatics. 2004;2(2):145–62.CrossRef Sporns O, Zwi JD. The small world of the cerebral cortex. Neuroinformatics. 2004;2(2):145–62.CrossRef
33.
Zurück zum Zitat Hosseini SM, Hoeft F, Kesler SR. GAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networks. PLoS ONE. 2012;7(7):e40709.CrossRef Hosseini SM, Hoeft F, Kesler SR. GAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networks. PLoS ONE. 2012;7(7):e40709.CrossRef
34.
Zurück zum Zitat Bassett DS, Bullmore E. Small-world brain networks. Neuroscientist. 2006;12(6):512–23.CrossRef Bassett DS, Bullmore E. Small-world brain networks. Neuroscientist. 2006;12(6):512–23.CrossRef
35.
Zurück zum Zitat Sporns O. The human connectome: a complex network. Ann N Y Acad Sci. 2011;1224(1):109–25.CrossRef Sporns O. The human connectome: a complex network. Ann N Y Acad Sci. 2011;1224(1):109–25.CrossRef
36.
Zurück zum Zitat Bassett DS, Bullmore E, Verchinski BA, Mattay VS, Weinberger DR, Meyer-Lindenberg A. Hierarchical organization of human cortical networks in health and schizophrenia. Journal of Neuroscience the Official Journal of the Society for Neuroscience. 2008;28(37):9239–48.CrossRef Bassett DS, Bullmore E, Verchinski BA, Mattay VS, Weinberger DR, Meyer-Lindenberg A. Hierarchical organization of human cortical networks in health and schizophrenia. Journal of Neuroscience the Official Journal of the Society for Neuroscience. 2008;28(37):9239–48.CrossRef
37.
Zurück zum Zitat Bernhardt BC, Zhang C, Yong H, Evans AC, Neda B. Graph-theoretical analysis reveals disrupted small-world organization of cortical thickness correlation networks in temporal lobe epilepsy. Cereb Cortex. 2011;21(9):2147–57.CrossRef Bernhardt BC, Zhang C, Yong H, Evans AC, Neda B. Graph-theoretical analysis reveals disrupted small-world organization of cortical thickness correlation networks in temporal lobe epilepsy. Cereb Cortex. 2011;21(9):2147–57.CrossRef
38.
Zurück zum Zitat Zhang Y, Lin L, Lin CP, Zhou Y, Chou KH, Lo CY, Su TP, Jiang T. Abnormal topological organization of structural brain networks in schizophrenia. Schizophr Res. 2012;141(2–3):109–18.CrossRef Zhang Y, Lin L, Lin CP, Zhou Y, Chou KH, Lo CY, Su TP, Jiang T. Abnormal topological organization of structural brain networks in schizophrenia. Schizophr Res. 2012;141(2–3):109–18.CrossRef
39.
Zurück zum Zitat Palaniyappan L, Marques TR, Taylor H, Mondelli V, Reinders AATS, Bonaccorso S, Giordano A, Diforti M, Simmons A, David AS. Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification. Schizophr Bull. 2016;42(6):1446–56.CrossRef Palaniyappan L, Marques TR, Taylor H, Mondelli V, Reinders AATS, Bonaccorso S, Giordano A, Diforti M, Simmons A, David AS. Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification. Schizophr Bull. 2016;42(6):1446–56.CrossRef
40.
Zurück zum Zitat Palaniyappan L, Park B, Balain V, Dangi R, Liddle P. Abnormalities in structural covariance of cortical gyrification in schizophrenia. Brain Struct Funct. 2015;220(4):2059–71.CrossRef Palaniyappan L, Park B, Balain V, Dangi R, Liddle P. Abnormalities in structural covariance of cortical gyrification in schizophrenia. Brain Struct Funct. 2015;220(4):2059–71.CrossRef
41.
Zurück zum Zitat Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Research: Neuroimaging. 2008;164(3):215–22.CrossRef Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Research: Neuroimaging. 2008;164(3):215–22.CrossRef
42.
Zurück zum Zitat Matsumoto N, Hanakawa T, Maki S, Graybiel AM, Kimura M. Nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner. J Neurophysiol. 1999;82(2):978–98.CrossRef Matsumoto N, Hanakawa T, Maki S, Graybiel AM, Kimura M. Nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner. J Neurophysiol. 1999;82(2):978–98.CrossRef
43.
Zurück zum Zitat Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res. 2003;64(1):53–62.CrossRef Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res. 2003;64(1):53–62.CrossRef
44.
Zurück zum Zitat Rigucci S, Dimitri-Valente G, Mandarelli G, Manfredi G, Comparelli A, De Filippis S, Gherardelli S, Bersani G, Girardi P, Ferracuti S. Neurological soft signs discriminate schizophrenia from bipolar disorder. J Psychiatr Pract®. 2014;20(2):147–53.CrossRef Rigucci S, Dimitri-Valente G, Mandarelli G, Manfredi G, Comparelli A, De Filippis S, Gherardelli S, Bersani G, Girardi P, Ferracuti S. Neurological soft signs discriminate schizophrenia from bipolar disorder. J Psychiatr Pract®. 2014;20(2):147–53.CrossRef
45.
Zurück zum Zitat Herold CJ, Duval CZ, Schröder J. Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study. Eur Arch Psychiatry Clin Neurosci. 2021;271(8):1465–73.CrossRef Herold CJ, Duval CZ, Schröder J. Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study. Eur Arch Psychiatry Clin Neurosci. 2021;271(8):1465–73.CrossRef
46.
Zurück zum Zitat Fleischer V, Koirala N, Droby A, Gracien RM, Deichmann R, Ziemann U, Meuth SG, Muthuraman M, Zipp F, Groppa S. Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord. 2019;12:1756286419838673.CrossRef Fleischer V, Koirala N, Droby A, Gracien RM, Deichmann R, Ziemann U, Meuth SG, Muthuraman M, Zipp F, Groppa S. Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord. 2019;12:1756286419838673.CrossRef
47.
Zurück zum Zitat Schröder J. Soft signs, neuroleptic side effects, and schizophrenia. Psychiatric Annals. 2003;33(3):214–20.CrossRef Schröder J. Soft signs, neuroleptic side effects, and schizophrenia. Psychiatric Annals. 2003;33(3):214–20.CrossRef
Metadaten
Titel
Neurological soft signs and structural network changes: a longitudinal analysis in first-episode schizophrenia
verfasst von
Li Kong
Christina J. Herold
Silke Bachmann
Johannes Schroeder
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Psychiatry / Ausgabe 1/2023
Elektronische ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-023-04522-4

Weitere Artikel der Ausgabe 1/2023

BMC Psychiatry 1/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.